Skip to main content
Premium Trial:

Request an Annual Quote

Cisbio, Integra Biosciences, Ambion

Premium

Cisbio has released the IP-One Assay System, an assay development tool based on the company's HTRF technology platform. The company said that the IP-One is the first high-throughput system that can easily detect inositol(1)phosphate, which is one of the major products of the phosphatidyl inositol cascade and tightly correlates with Gq-coupled activity.


Integra Biosciences has released the CELLspin, a compact system with remote control for spinning cell culture volumes from 100 ml to 1000 ml at 5 rpm to 75 rpm. Two CELLspin systems fit comfortably inside a standard size incubator, the company said.


Ambion has introduced its Pre-miR miRNA precursor molecules, which are chemically modified and optimized nucleic acids designed to mimic the microRNA molecules in cells, the company said. They are designed to directly enter into the miRNA processing pathway, and "are treated identically to endogenous miRNA within the cell. Since the … molecules directly enter the miRNA pathway, they eliminate any non-miRNA cellular response that is seen with siRNA-like designs." Additional details about the molecules can be found at http://www.ambion.com/catalog/CatNum.php?17110.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.